Submitted:
16 June 2025
Posted:
17 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Cholecystectomy in Cirrhosis
3.1. Pathophysiological Challenges of Cholecystectomy in Cirrhosis
3.2. Indications and Timing of Surgery: Elective vs. Emergency Cholecystectomy in Cirrhotic Patients
- a)
- Medically optimize the patient: manage ascites, rectify coagulopathy [administer fresh frozen plasma (when INR >1.5) and platelets (<50/mm3)];
- b)
- Cirrhotic individuals with hemoglobin levels below 10 g/dL should get corrective blood transfusions prior to abdominal surgery;
- c)
3.3. Surgical Techniques and Modifications: Laparoscopic vs. Open Approaches and Robotic Innovations
- Risk of collateral wound formation in the periumbilical region during optical trocar insertion;
- Hemorrhagic risk associated with vascular adhesions;
- Challenges in liver retraction and exposure of the Calot triangle;
- Hazardous approach to the vesicular pedicle in the context of portal hypertension;
- Hemorrhagic dissection of the vesicular bed. The challenges are further intensified in patients who have undergone surgery for acute or chronic cholecystitis [21].
3.4. Subtotal Cholecistectomy

4. Cholecistectomy in Sclero-Atrophic Cholecystitis
4.1. Etiopathogenesis of Sclero-Atrophic Cholecystitis
4.2. Surgical Considerations in Sclero-Atrophic Cholecystitis
5. Cholecistectomy in Gangrenous Cholecystitis
5.1. Pathogenesis and Risk Factors of Gangrenous Cholecystitis
5.2. Surgical Strategies in Gangrenous Cholecystitis
6. Conclusions
Limitations of the Study
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| GC | Gangrenous Cholecystitis |
| LC | Laparoscopic Cholecystectomy |
| PTGBD | Percutaneous Transhepatic Gallbladder Drainage |
| OC | Open Cholecystectomy |
| RC | Robotic-Assisted Cholecystectomy |
| SAC | Sclero-Atrophic Cholecystitis |
| CVS | Critical View of Safety |
| SC | Subtotal Cholecystectomy |
| IOC | Intraoperative Cholangiography |
| ICG | Fluorescence-Guided Imaging With Indocyanine Green |
| US | Ultrasound |
References
- M. W. Jones, E. Guay, and J. G. Deppen, Open Cholecystectomy. 2024.
- S. O’Brien et al., “Adverse outcomes and short-term cost implications of bile duct injury during cholecystectomy,” Surg Endosc, vol. 34, no. 2, pp. 628–635, Feb. 2020. [CrossRef]
- L. M. Stinton and E. A. Shaffer, “Epidemiology of gallbladder disease: cholelithiasis and cancer,” Gut Liver, vol. 6, no. 2, pp. 172–187, Apr. 2012. [CrossRef]
- S. M. Strasberg, “Clinical practice. Acute calculous cholecystitis.,” N Engl J Med, vol. 358, no. 26, pp. 2804–11, Jun. 2008. [CrossRef]
- F. Cauchy, E. Vibert, and L. Barbier, “What are the Specifics of Biliary Surgery in Cirrhotic Patients?,” Chirurgia (Bucur), vol. 115, no. 2, pp. 191–207, 2020. [CrossRef]
- Y. Zhang, D. Liu, Q. Ma, C. Dang, W. Wei, and W. Chen, “Factors influencing the prevalence of gallstones in liver cirrhosis,” J Gastroenterol Hepatol, vol. 21, no. 9, pp. 060616025538010-???, Jun. 2006. [CrossRef]
- M. Acalovschi, “Gallstones in patients with liver cirrhosis: Incidence, etiology, clinical and therapeutical aspects,” World Journal of Gastroenterology: WJG, vol. 20, no. 23, p. 7277, Jun. 2014. [CrossRef]
- S. Y. Wang, C. N. Yeh, Y. Y. Jan, and M. F. Chen, “Management of Gallstones and Acute Cholecystitis in Patients with Liver Cirrhosis: What Should We Consider When Performing Surgery?,” Gut Liver, vol. 15, no. 4, p. 517, 2020. [CrossRef]
- N. Abbas, J. Makker, H. Abbas, and B. Balar, “Perioperative Care of Patients With Liver Cirrhosis: A Review,”vol. 10, Feb. 2017. [CrossRef]
- D. Carpenter, P. Liou, and A. Mathur, “Management of Patients with Cirrhosis and Portal Hypertension Requiring Surgery,” Dig Dis Interv, vol. 04, no. 02, pp. 168–179, Jun. 2020. [CrossRef]
- M. A. Harmouch and M. J. Hobeika, “Perioperative Management of the Cirrhotic Patient,” Common Problems in Acute Care Surgery, pp. 43–54, 2017. [CrossRef]
- R. Rai, S. Nagral, and A. Nagral, “Surgery in a Patient with Liver Disease,” J Clin Exp Hepatol, vol. 2, no. 3, p. 238, Sep. 2012. [CrossRef]
- R. S. Pinheiro et al., “Laparoscopic cholecystectomy and cirrhosis: patient selection and technical considerations,” Ann Laparosc Endosc Surg, vol. 2, no. 3, pp. 35–35, Mar. 2017. [CrossRef]
- K. T. Nguyen et al., “Cirrhosis is not a contraindication to laparoscopic cholecystectomy: Results and practical recommendations,” HPB, vol. 13, no. 3, pp. 192–197, 2011. [CrossRef]
- S. Delis, A. Bakoyiannis, J. Madariaga, J. Bramis, N. Tassopoulos, and C. Dervenis, “Laparoscopic cholecystectomy in cirrhotic patients: The value of MELD score and ChildPugh classification in predicting outcome,” Surg Endosc, vol. 24, no. 2, pp. 407–412, 2010. [CrossRef]
- K. E. Diaz and T. D. Schiano, “Evaluation and Management of Cirrhotic Patients Undergoing Elective Surgery,” Curr Gastroenterol Rep, vol. 21, no. 7, pp. 1–11, Jul. 2019. [CrossRef]
- Puggioni and L. L. Wong, “A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis,” J Am Coll Surg, vol. 197, no. 6, pp. 921–926, Dec. 2003. [CrossRef]
- Adiamah, C. J. Crooks, J. S. Hammond, P. Jepsen, J. West, and D. J. Humes, “Cholecystectomy in patients with cirrhosis: a population-based cohort study from England,” HPB, vol. 25, no. 2, pp. 189–197, Feb. 2023. [CrossRef]
- W. Ke and S. D. Wu, “Comparison of Emergency Cholecystectomy with Delayed Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in Patients with Moderate Acute Cholecystitis,” https://home.liebertpub.com/lap, vol. 28, no. 6, pp. 705–712, Jun. 2018. [CrossRef]
- S. Z. Huang et al., “Comparison of emergency cholecystectomy and delayed cholecystectomy after percutaneous transhepatic gallbladder drainage in patients with acute cholecystitis: a systematic review and meta-analysis,” Updates Surg, vol. 73, no. 2, pp. 481–494, Apr. 2021. [CrossRef]
- Palanivelu et al., “Laparoscopic Cholecystectomy in Cirrhotic Patients: The Role of Subtotal Cholecystectomy and Its Variants,” J Am Coll Surg, vol. 203, no. 2, pp. 145–151, Aug. 2006. [CrossRef]
- H. Aziz et al., “A potential role for robotic cholecystectomy in patients with advanced liver disease: Analysis of the NSQIP database,” American Surgeon, vol. 86, no. 4, pp. 341–345, Apr. 2020. [CrossRef]
- H. Aziz, K. Hanna, N. Lashkari, N. U. S. Ahmad, Y. Genyk, and M. R. Sheikh, “Hospitalization Costs and Outcomes of Open, Laparoscopic, and Robotic Liver Resections,” American Surgeon, vol. 88, no. 9, pp. 2331–2337, Sep. 2022. [CrossRef]
- M. Wong and R. W. Busuttil, “Surgery in Patients with Portal Hypertension,” Clin Liver Dis, vol. 23, no. 4, pp. 755–780, Nov. 2019. [CrossRef]
- Cassinotti, L. Baldari, L. Boni, S. Uranues, and A. Fingerhut, “Laparoscopic Cholecystectomy in the Cirrhotic: Review of Literature on Indications and Technique,” Chirurgia (Bucur), vol. 115, no. 2, p. 208, 2020. [CrossRef]
- H. Aziz et al., “A potential role for robotic cholecystectomy in patients with advanced liver disease: Analysis of the NSQIP database,” American Surgeon, vol. 86, no. 4, pp. 341–345, Apr. 2020. [CrossRef]
- Shimizu, M. Ito, and A. K. Lefor, “Laparoscopic and Robot-Assisted Hepatic Surgery: An Historical Review,” Journal of Clinical Medicine 2022, Vol. 11, Page 3254, vol. 11, no. 12, p. 3254, Jun. 2022. [CrossRef]
- Bozkurt, J. P. Sijberden, and M. A. Hilal, “What Is the Current Role and What Are the Prospects of the Robotic Approach in Liver Surgery?,” Cancers 2022, Vol. 14, Page 4268, vol. 14, no. 17, p. 4268, Aug. 2022. [CrossRef]
- M. Elshaer, G. Gravante, K. Thomas, R. Sorge, S. Al-Hamali, and H. Ebdewi, “Subtotal cholecystectomy for ‘Difficult gallbladders’: Systematic review and meta-analysis,” JAMA Surg, vol. 150, no. 2, pp. 159–168, Feb. 2015. [CrossRef]
- Kohga et al., “Calculus left in remnant gallbladder cause long-term complications in patients undergoing subtotal cholecystectomy,” HPB, vol. 21, no. 4, pp. 508–514, Apr. 2019. [CrossRef]
- W. M. Tay et al., “Subtotal cholecystectomy: early and long-term outcomes,” Surg Endosc, vol. 34, no. 10, pp. 4536–4542, Oct. 2020. [CrossRef]
- H. van Dijk et al., “Short- and Long-Term Outcomes after a Reconstituting and Fenestrating Subtotal Cholecystectomy,” J Am Coll Surg, vol. 225, no. 3, pp. 371–379, Sep. 2017. [CrossRef]
- L. A. Meirelles-Costa, C. J. C. Bresciani, R. O. Perez, B. H. Bresciani, S. A. C. Siqueira, and I. Cecconello, “Are histological alterations observed in the gallbladder precancerous lesions?,” Clinics, vol. 65, no. 2, pp. 143–150, Feb. 2010. [CrossRef]
- J. Zemour, M. Marty, B. Lapuyade, D. Collet, and L. Chiche, “Gallbladder tumor and pseudotumor: Diagnosis and management,” J Visc Surg, vol. 151, no. 4, pp. 289–300, Sep. 2014. [CrossRef]
- V. de Paula Reis Guimarães et al., “A comprehensive exploration of gallbladder health: from common to rare imaging findings,” Abdominal Radiology, vol. 50, no. 1, pp. 131–151, Jan. 2024. [CrossRef]
- S. K. B., V. Reddy, S. R. V., R. M. C., and J. Koneru, “A study of clinical presentations and management of cholelithiasis,” International Surgery Journal, vol. 6, no. 6, pp. 2164–2167, May 2019. [CrossRef]
- M. Beuran, I. Ivanov, and M. D. Venter, “Gallstone Ileus–Clinical and therapeutic aspects,” J Med Life, vol. 3, no. 4, p. 365, Oct. 2010. Available online: https://pmc.ncbi.nlm.nih.gov/articles/PMC3019077/ (accessed on 5 May 2025).
- Ferrozzi, G. Garlaschi, and D. Bova, “Anatomical Sites of Metastatic Colonization,” CT of Metastases, pp. 27–80, 2000. [CrossRef]
- M. Akoǧlu, M. Ercan, E. B. Bostanci, Z. Teke, and E. Parlak, “Surgical outcomes of laparoscopic cholecystectomy in scleroatrophic gallbladders,” Turkish Journal of Gastroenterology, vol. 21, no. 2, pp. 156–162, Jun. 2010. [CrossRef]
- E. E. Montalvo-Javé, E. A. Ayala-Moreno, E. H. Contreras-Flores, and M. A. Mercado, “Strasberg’s Critical View: Strategy for a Safe Laparoscopic Cholecystectomy,” Euroasian J Hepatogastroenterol, vol. 12, no. 1, pp. 40–44, Jul. 2022. [CrossRef]
- S. Abdallah, M. H. Sedky, and Z. H. Sedky, “The difficult laparoscopic cholecystectomy: a narrative review,” BMC Surg, vol. 25, no. 1, pp. 1–17, Dec. 2025. [CrossRef]
- Missori, F. Serra, and R. Gelmini, “A narrative review about difficult laparoscopic cholecystectomy: technical tips,” Laparosc Surg, vol. 6, no. 0, Jul. 2022. [CrossRef]
- S. Duca et al., “Laparoscopic cholecystectomy: Incidents and complications. A retrospective analysis of 9542 consecutive laparoscopic operations,” HPB, vol. 5, no. 3, pp. 152–158, Aug. 2003. [CrossRef]
- Fingerhut, P. Shukla, M. Soltès, and I. Khatkov, “Cholecystectomy for Complicated Biliary Disease of the Gallbladder,” Emergency Surgery Course (ESC®) Manual: The Official ESTES/AAST Guide, pp. 139–145, Mar. 2016. [CrossRef]
- V. K. Kapoor, “Mechanisms of Causation of Bile Duct Injury,” Post-cholecystectomy Bile Duct Injury, pp. 21–35, Apr. 2020. [CrossRef]
- Y. Iwashita et al., “Delphi consensus on bile duct injuries during laparoscopic cholecystectomy: an evolutionary cul-de-sac or the birth pangs of a new technical framework?,” J Hepatobiliary Pancreat Sci, vol. 24, no. 11, pp. 591–602, Nov. 2017. [CrossRef]
- K. D. Peker and H. Aliş, “Laparoscopic subtotal cholecystectomy could be an alternative to conversion,” Medical Journal of Bakirkoy, vol. 13, no. 3, pp. 113–117, 2017. [CrossRef]
- Y. Iwashita et al., “Delphi consensus on bile duct injuries during laparoscopic cholecystectomy: an evolutionary cul-de-sac or the birth pangs of a new technical framework?,” J Hepatobiliary Pancreat Sci, vol. 24, no. 11, pp. 591–602, Nov. 2017. [CrossRef]
- A. Zaman and T. P. Singh, “The emerging role for robotics in cholecystectomy: the dawn of a new era?,” Hepatobiliary Surg Nutr, vol. 7, no. 1, p. 21, Feb. 2018. [CrossRef]
- Önder, M. Kapan, B. V. Ülger, A. Oǧuz, A. Türkoǧlu, and Ö. Uslukaya, “Gangrenous Cholecystitis: Mortality and Risk Factors,” Int Surg, vol. 100, no. 2, pp. 254–260, Feb. 2015. [CrossRef]
- P. G. Marinova, “Predictors for Gangrene and Perforation of Gallbladder Wall in Patients with Acute Cholecystitis,” Journal of Biomedical and Clinical Research, vol. 16, no. 2, pp. 146–152, Nov. 2023. [CrossRef]
- N. Fabbri et al., “Enhancing the management of acute and gangrenous cholecystitis: a systematic review supported by the TriNetX database,” Transl Gastroenterol Hepatol, vol. 10, no. 0, Jan. 2025. [CrossRef]
- Tsalikidis et al., “Gallbladder perforation. A case series and review of the literature.,” Ann Ital Chir, vol. 91, Dec. 2020.
- V. Gupta et al., “The Multifaceted Impact of Gallstones: Understanding Complications and Management Strategies,” Cureus, vol. 16, no. 6, Jun. 2024. [CrossRef]
- M. Yokoe et al., “Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos),” J Hepatobiliary Pancreat Sci, vol. 25, no. 1, pp. 41–54, Jan. 2018. [CrossRef]
- S. Loozen, M. M. Blessing, B. van Ramshorst, H. C. van Santvoort, and D. Boerma, “The optimal treatment of patients with mild and moderate acute cholecystitis: time for a revision of the Tokyo Guidelines,” Surg Endosc, vol. 31, no. 10, pp. 3858–3863, Oct. 2017. [CrossRef]
- M. Pisano et al., “2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis,” World Journal of Emergency Surgery 2020 15:1, vol. 15, no. 1, pp. 1–26, Nov. 2020. [CrossRef]
- N. Fabbri et al., “Enhancing the management of acute and gangrenous cholecystitis: a systematic review supported by the TriNetX database,” Transl Gastroenterol Hepatol, vol. 10, no. 0, Jan. 2025. [CrossRef]
- B. Oh, E. Kim, E. J. Ahn, J.-M. Park, and and S.-H. Park, “The Benefits of Percutaneous Transhepatic Gallbladder Drainage prior to Laparoscopic Cholecystectomy for Acute Cholecystitis,” Journal of Minimally Invasive Surgery, vol. 19, no. 2, pp. 63–69, Jun. 2016. [CrossRef]
- Melloul, A. Denys, N. Demartines, J. M. Calmes, and M. Schäfer, “Percutaneous drainage versus emergency cholecystectomy for the treatment of acute cholecystitis in critically Ill patients: Does it matter?,” World J Surg, vol. 35, no. 4, pp. 826–833, Apr. 2011. [CrossRef]
- R. K. Morcos et al., “Outcomes of Gallbladder Drainage Techniques in Acute Cholecystitis: Percutaneous Versus Endoscopic Methods,” Cureus, vol. 16, no. 11, Nov. 2024. [CrossRef]
- R. Navuluri, M. Hoyer, M. Osman, and J. Fergus, “Emergent Treatment of Acute Cholangitis and Acute Cholecystitis,” Semin Intervent Radiol, vol. 37, no. 1, pp. 14–23, Mar. 2020. [CrossRef]
- Y. Yang, Q. Chen, Y. Hu, L. Zhao, P. Cai, and S. Guo, “Cholecystopleural fistula: A case report and literature review,” Medicine (United States), vol. 103, no. 33, p. e39366, Aug. 2024. [CrossRef]
- H.R, “Narrative Review on Complicated Cholecystitis: An Update on Management,” Asian Journal of Medicine and Health, vol. 22, no. 8, pp. 98–105, Jul. 2024. [CrossRef]
- Nve, J. M. Badia, M. Amillo-Zaragüeta, M. Juvany, M. Mourelo-Fariña, and R. Jorba, “Early Management of Severe Biliary Infection in the Era of the Tokyo Guidelines,” Journal of Clinical Medicine 2023, Vol. 12, Page 4711, vol. 12, no. 14, p. 4711, Jul. 2023. [CrossRef]
| Vesicular bed haemorrhage | Insufficient visualization | Adhesions | Inflammation | Other |
|---|---|---|---|---|
| 41.3% | 26.1% | 13.0% | 6.5% | 13.0% |
| Technique | Indication in SAC | Risk Mitigation | Comment |
|---|---|---|---|
| Fundus-First Approach |
Dense adhesions blocking Calot’s triangle | Avoids dissection in unsafe area | Risk of wrong dissection plane |
| Subtotal Cholecystectomy |
Inflammation obliterates anatomy | Avoids BDI | Watch for residual stones |
| Intraoperative Cholangiography |
Unclear anatomy | Confirms ductal structures |
Requires equipment and skill |
| Conversion to Open | Laparoscopic access unsafe | Enhanced tactile feedback |
Should not be delayed |
| Grade I (mild) |
Does not meet the criteria of grade II or grade III acute cholecystitis. Can also be defined as acute cholecystitis in a healthy patient with no organ dysfunction and mild inflammatory changes in the gallbladder. |
| Grade II (moderate) |
Associated with any one of the following conditions: |
| 1.Elevated white blood cell count (18,000/nm3) | |
| 2.Palpable tender mass in the right upper abdominal quadrant | |
| 3.Duration of complaints 72h | |
| 4.Marked local inflammation (GC, pericholecystic abscess, biliary peritonitis, emphysematous cholecystitis) | |
| Grade III (severe) |
Associated with dysfunction of any of the following organs/systems: |
| 1.Cardiovascular dysfunction (Hypotension requiring treatment with dopamine 5µg/kg or any dose of norepinephrine) | |
| 2.Neurological dysfunction (decreased level of consciousness) | |
| 3.Respiratory dysfunction (PaO2FiO2 ratio 300) | |
| 4.Renal dysfunction (oliguria, creatinine 2,0 mg/dl) | |
| 5.Hepatic dysfunction (PT-INR 1,5) | |
| 6. Hematological dysfunction (platelet count 100,000/mm3) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).